| Zugriffe | |
|---|---|
| Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis | 321 |
| Januar 2025 | Februar 2025 | März 2025 | April 2025 | Mai 2025 | Juni 2025 | Juli 2025 | |
|---|---|---|---|---|---|---|---|
| Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis | 9 | 11 | 3 | 6 | 2 | 1 | 1 |
| Zugriffe | |
|---|---|
| 1065.full.pdf | 173 |
